B-CELL LYMPHOMA STAGE I

B-CELL LYMPHOMA STAGE I was reported 33 times

B-CELL LYMPHOMA STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Integrin Receptor Antagonist [EPC] 4 0.0000
1 Thiazide Diuretic [EPC] 4 0.0000
2 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
3 Interferon beta [EPC] 3 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
5 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
6 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
8 Aminosalicylate [EPC] 1 0.0000
9 Interleukin-12 Antagonist [EPC] 1 0.0000
10 Interleukin-23 Antagonist [EPC] 1 0.0000
11 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
12 Proteasome Inhibitor [EPC] 1 0.0000
13 Alkylating Drug [EPC] 2 0.0000
14 Thalidomide Analog [EPC] 4 0.0000
15 Vitamin D [EPC] 2 0.0000
16 beta-Adrenergic Blocker [EPC] 2 0.0000
17 Aldosterone Antagonist [EPC] 1 0.0000
18 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
19 Vitamin B12 [EPC] 2 0.0000
20 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
21 RANK Ligand Inhibitor [EPC] 1 0.0000
22 Vitamin C [EPC] 2 0.0000
23 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
24 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
25 Factor Xa Inhibitor [EPC] 1 0.0000
26 Osmotic Laxative [EPC] 1 0.0000
27 Corticosteroid [EPC] 4 0.0000
28 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
29 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
30 GLP-1 Receptor Agonist [EPC] 1 0.0000
31 Loop Diuretic [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000